Korea is expected to spend around 6 trillion won ($4.6 billion) this year on treating diseases related to aging such as ...

RESEARCH TRIANGLE PARK, N.C. - BioCryst Pharmaceuticals , Inc. (NASDAQ:BCRX), a biotechnology company with impressive revenue growth of nearly 30% over the last twelve months, has announced that ...

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that Infarmed in Portugal has recommended ORLADEYO® ...

KalVista Pharmaceuticals, Inc. , today announced the presentation of novel data related to long-term prophylaxis and sebetralstat at the Western Society of Allergy, Asthma & Immunology (WSAAI) 2025 ...

At only 27 years old, Daniela Powers felt like she was dying. What began as unexplained rashes exploded into a debilitating ...

A woman suffering debilitating symptoms is crediting WVU Medicine for giving her her life back after finally receiving a ...

Could the key to easing anxiety be hidden in our gut? Scientists have discovered a crucial connection between gut microbes and anxiety-related behavior. Their research suggests that microbial ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved CSL’s Andembry (garadacimab) to prevent ...

The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...

Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...

Celltrion announced on Friday that its biosimilar Avtozma, a version of the autoimmune disease treatment Actemra (active ingredient tocilizumab), has received product approval from the US Food and ...

Degenerative disk disease is a progressive condition in which spinal disks deteriorate. Surgery is an option, but less invasive treatments and therapies may also help. Degenerative disk disease is ...